Neumora Therapeutics Announces IPO Of 14.71 Mln Shares To Be Priced Between $16.00 And $18.00/Share

RTTNews | 637 dias atrás
Neumora Therapeutics Announces IPO Of 14.71 Mln Shares To Be Priced Between $16.00 And $18.00/Share

(RTTNews) - Biopharmaceutical company Neumora Therapeutics, Inc. revealed Monday that it will offer 14.71 million shares of its common stock in an initial public offering and expects the IPO price to be between $16.00 and $18.00 per share, according to an amended Form S-1 filing with the U.S. Securities and Exchange Commission.

The Watertown, Massachusetts-based company has applied to list its common stock on The Nasdaq Global Market (Nasdaq) under the symbol "NMRA."

The company has granted the underwriters an option for a period of 30 days to purchase up to an additional 2.21 million shares of its common stock.

The company estimates that its net proceeds from this offering will be approximately $227.5 million (or approximately $262.3 million if the underwriters exercise in full their option to purchase additional shares of common stock), based on an assumed IPO price of $17.00 per share.

The company intends to use the net proceeds, together with existing cash, cash equivalents and marketable securities, to fund the clinical and preclinical development of current programs, to fund research and development activities for additional programs, and the remainder for working capital and other general corporate purposes.

The remainder of the net proceeds may also be used to in-license, acquire, or invest in, complementary technologies, assets, or intellectual property.

read more
European Stocks Close Weak After Cautious Session

European Stocks Close Weak After Cautious Session

European markets settled lower on Monday after a subdued performance as investors awaited the outcome of U.S.-China high-level trade talks in London. Also, a lack of regional economic data and earnings news contributed to the cautious mood in the markets.
RTTNews | 25 minutos atrás
FDA, CDC Probe Salmonella Outbreak As Around 1.70 Mln Dozen Brown Eggs Recalled

FDA, CDC Probe Salmonella Outbreak As Around 1.70 Mln Dozen Brown Eggs Recalled

The U.S. Food and Drug Administration and the Centers for Disease Control and Prevention or CDC are investigating a Salmonella Enteritidis outbreak linked to brown eggs that sickened nearly 79 across 7 states. Associated with the ongoing probe, August Egg Co. recalled around 1.70 million dozen brown cage-free and brown certified organic eggs sold through Walmart and other retail locations.
RTTNews | 4h 11min atrás
Bay Street May Open Slightly Higher

Bay Street May Open Slightly Higher

Canadian shares may open slightly higher on Monday amid optimism about some positive progress in U.S.-China trade talks. Energy stocks are likely to find some support on higher crude oil prices.. The U.S.-China discussions will aim to resolve some major trade disputes between the two major economies.
RTTNews | 6h 3min atrás
FTSE 100 Down Marginally At Noon

FTSE 100 Down Marginally At Noon

The U.K. market is down marginally at noon on Monday with investors mostly making cautious moves amid a lack of triggers. The focus is on trade talks between the U.S. and Chinese officials in London. Weak Chinese exports data weighs on sentiment.
RTTNews | 7h 15min atrás
CAC 40 Down Slightly In Lackluster Trade

CAC 40 Down Slightly In Lackluster Trade

French stocks are down slightly in lackluster trade on Monday with investors refraining from making significant moves as they await the high-level trade talks between U.S. and Chinese officials in London later in the day.
RTTNews | 7h 36min atrás
DAX Down Over 0.5% In Cautious Trade

DAX Down Over 0.5% In Cautious Trade

German stocks are down in negative territory on Monday as investors make cautious moves while awaiting crucial talks between U.S. and Chinese officials in London later in the day. The discussions will aim to resolve some major trade disputes between the two major economies. Treasury Secretary Scott Bessent leads the U.S. delegation in the high-level trade talks.
RTTNews | 7h 57min atrás
Church & Dwight Recalls All Lots Of Zicam Nasal, Orajel Teething Swabs

Church & Dwight Recalls All Lots Of Zicam Nasal, Orajel Teething Swabs

Church & Dwight Co., Inc. has called back all lots of Zicam nasal swabs and Orajel baby teething swabs citing potential microbial contamination, according to the U.S. Food and Drug Administration. Cold remedy nasal swabs are a zinc-free, homeopathic cold remedy swab designed to shorten the duration of the common cold
RTTNews | 8h 35min atrás